U.S. flag

An official website of the United States government

NM_000551.4(VHL):c.278_279delinsTT (p.Gly93Val) AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 18, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001016587.3

Allele description

NM_000551.4(VHL):c.278_279delinsTT (p.Gly93Val)

Gene:
VHL:von Hippel-Lindau tumor suppressor [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_000551.4(VHL):c.278_279delinsTT (p.Gly93Val)
HGVS:
  • NC_000003.12:g.10142125_10142126delinsTT
  • NG_008212.3:g.5491_5492delinsTT
  • NM_000551.4:c.278_279delinsTTMANE SELECT
  • NM_001354723.2:c.278_279delinsTT
  • NM_198156.3:c.278_279delinsTT
  • NP_000542.1:p.Gly93Val
  • NP_001341652.1:p.Gly93Val
  • NP_937799.1:p.Gly93Val
  • LRG_322:g.5491_5492delinsTT
  • NC_000003.11:g.10183809_10183810delinsTT
  • NM_000551.3:c.278_279delGCinsTT
Protein change:
G93V
Links:
dbSNP: rs1559426072
NCBI 1000 Genomes Browser:
rs1559426072
Molecular consequence:
  • NM_000551.4:c.278_279delinsTT - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354723.2:c.278_279delinsTT - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198156.3:c.278_279delinsTT - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001177553Ambry Genetics
criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)
Likely pathogenic
(Jun 18, 2020)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

[Retinal capillary angioma. Clinical and molecular genetic studies].

Kreusel KM, Bornfeld N, Bender BU, Neumann L, Foerster MH, Neumann HP.

Ophthalmologe. 1999 Feb;96(2):71-6. German.

PubMed [citation]
PMID:
10095351

DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations.

Klein B, Weirich G, Brauch H.

Hum Genet. 2001 May;108(5):376-84.

PubMed [citation]
PMID:
11409863
See all PubMed Citations (9)

Details of each submission

From Ambry Genetics, SCV001177553.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (9)

Description

The c.278_279delGCinsTT variant (also known as p.G93V), located in coding exon 1 of the VHL gene, results from an in-frame deletion of GC and insertion of TT at nucleotide positions 278 to 279. This results in the substitution of the glycine residue for a valine residue at codon 93, an amino acid with dissimilar properties. An variant resulting in the same amino acid substitution, p.G93V (c.278G>T), has been reported in a cohort of patients with non-syndromic pheochromocytoma (Neumann HP et al. N. Engl. J. Med., 2002 May;346:1459-66). Further, other missense variants at this codon (p.G93D, p.G93S, p.G93R, p.G93C) have been reported in numerous individuals with personal and/or family history consistent with Von Hippel-Lindau syndrome (VHL) (Chen F et al. Hum. Mutat., 1995;5:66-75; Zbar B et al. Hum. Mutat., 1996;8:348-57; Glavac D et al. Hum. Genet., 1996 Sep;98:271-80; Neumann HP et al. N. Engl. J. Med., 2002 May;346:1459-66; Klein B et al. Hum. Genet., 2001 May;108:376-84; Schreinemakers JM et al. World J Surg Oncol, 2007 Oct;5:112; Iacobone M et al. Surgery, 2011 Dec;150:1194-201). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Mar 5, 2024